Abstract:OBJECTIVE:To investigate the effect of subcutaneous transplantation of microencapsulated Chinese hamster ovary cells (CHO)/pcDNA3.1/mIL-12 and subcutaneous transplantation of microencapsulated CHO/pcDNA3.1/mIL-12 combined with 5-fluoro-uracilum (5-FU) in treatment of tumor-burdened mice.METHODS:CHO/pcDNA3.1/mIL-12 and CHO/pcDNA3.1 were suspended in solution of sodium alginate and made into microcapsules. Sixty mice were divided into 6 groups of 10 mice: (1) IL-12 group, microencapsulated CHO/pcDNA3.1/mIL-12 was injected subcutaneously, (2) combined treatment group: CHO/pcDN with 5-FU, (3) 5-FU group: 5-FU was injected intraperitoneally, (4) blank vector group: CHO/pcDNA3.1 was injected subcutaneously, (5) tumor-burdened group: without any treatment, and (6) blank control group: normal mice without any treatment. Except the mice of the blank control group, all mice were injected subcutaneously into the inner side of right thigh with mice colonic adenoma cells. The volume of tumor was measured every third day. 20 days after the treatment, 5 mice in each group were killed to examine the serum Th1 type cytokines: interferon (IFN)-gamma, IL-12, and Th2 type cytokins: IL-4, IL-10 by double antibody sandwich ELISA. The spleens were made into suspension of lymphocytes to examine the activity of natural killer cell (NK) and cytolytic T lymphocyte (CTL). The survival period of the remaining 5 mice in each group was observed till the 60th day.RESULTS:The activity of NK and CTL were significantly much more in the IL-12 group than in other groups. The activity of NK was significantly much more in combined treatment group than in the tumor-burdened group. The levels of Th1 type cytokines were the lowest in the tumor-burdened group. There was no difference in the levels of Th1 type cytokine between the tumor-burdened group and 5-FU group. However, the levels of Th1 type cytokine were significantly higher in the IL-12 group than in other groups. The levels of Th2 type cytokines were rather high in the tumor-burdened group. There was no difference in the levels of Th2 type cytokine between the tumor-burdened group and 5-FU group. However, the levels of Th2 type cytokine were the lowest in the IL-12 group than in other groups. There was no significant difference in volume of tumor among the tumor-burdened group, blank vector group, and 5-FU group. The mean diameters of tumor in the IL-12 group and combined treatment group were significantly smaller than in the 5-FU, tumor-burdened, and blank vector groups (P < 0.05), however, without a difference between the IL-12 group and combined treatment group. The survival periods of the IL-12 group and combined treatment group were significantly longer than those in the blank vector, tumor-burdened and 5-FU groups (P < 0.05).CONCLUSION:Microencapsulated CHO/pcDNA3.1/mIL-12 transplanted subcutaneously significantly improves the immune function of tumor-burdened mice and partially overcomes immune suppression caused by chemotherapy, and is effective in slowing the growth of tumor and lengthening the survival period of tumor-burdened ice.

Effects of Fibroblast-Mediated Interleukin 3 and Interleukin 6 Gene Therapy on Hematopoiesis in Mice Treated with 5-Fluorouracil

ACCELERATED RECOVERY OF IRRADIATION-INDUCED BONE MARROW DEPRESSION BY FIBROBLAST-MEDIATED INTERLEUKIN 6 GENE THERAPY IN COMBINATION WITH BONE MARROW TRANSPLANTATION IN MICE1

Echinacoside Improves Hematopoietic Function in 5-Fu-induced Myelosuppression Mice

[Effect of Fluorouracil-inducible GM-CSF Gene Therapy Regulated by Egr-1 Promoter on Chemotherapeutic Hematopoietic Damage of Tumor-Bearing Mice].

Irradiation Haematopoiesis Recovery Orchestrated by IL-12/IL-12R1/TYK2/STAT3-Initiated Osteogenic Differentiation of Mouse Bone Marrow-Derived Mesenchymal Stem Cells

Osteogenic Effects of IL-12 on Bone Marrow Mesenchymal Stem Cells Facilitates Its Irradiation Hematopoiesis Recovery

[Subcutaneous Transplantation of Microencapsulated Chinese Hamster Ovary (CHO) Cells/pcdna 3.1/Mil-12 and Subcutaneous Transplantation of Microencapsulated CHO/pcDNA3.1/mIL-12 Combined with 5-Fluoro-uracil in Treatment of Tumor-Burdened Mice].

Efficient activation of antitumor immunity by IL-6 gene-modified leukemia vaccine in combination with low dose cyclophosphamide and low dose IL-2

[Experimental study on the treatment of human hepatocellular carcinoma by fibroblast-mediated human IFN-alpha gene therapy in combination with adoptive chemoimmunotherapy].

[Therapeutic Effect of Combined Cytokines on Nonhuman Primate Model of Severe Haemopoietic Acute Radiation Sickness].

[Study on the Effects of Combined IL-12 and GM-CSF Gene Therapy for Murine Liver Cancer].

[Accelerating Hematopoietic Recovery in Allogeneic Bone Marrow Transplantation Mice by Co-Infusion of Marrow Stromal Cells Transduced with Dual Genes of IL-3/IL-6].

Radioprotective Effect of FLT3 Ligand Expression Regulated by Egr-1 Regulated Element on Radiation Injury of SCID Mice.

Ex Vivo Activated Immune Cells Promote Survival and Stimulate Multilineage Hematopoietic Recovery in Myelosuppressed Mice

Immunological Effects of Vaccines Combined with Granulocyte Colony-Stimulating Factor on a Murine WEHI-3 Leukemia Model

Therapeutic effects of combined suicide gene and cytokine gene therapy on erythroleukemia-bearing mice]

Enhanced antitumor effects of suicide gene therapy by simultaneous transfer of GM-CSF gene in leukemia-bearing mice

Administration of granulocyte colony-stimulating factor ameliorates radiation-induced hepatic fibrosis in mice

Interleukin-3 in hematology and oncology: current state of knowledge and future directions

Inhibition of TGF-β Signaling in Bone Marrow Endothelial Cells Promotes Hematopoietic Recovery in Acute Myeloid Leukemia Patients

Combined IL-12 and GM-CSF gene therapy for murine hepatocellular carcinoma